MDPI and ACS Style
Giampietro, L.; Marinacci, B.; Della Valle, A.; D’Agostino, I.; Lauro, A.; Mori, M.; Carradori, S.; Ammazzalorso, A.; De Filippis, B.; Maccallini, C.;
et al. Azobenzenesulfonamide Carbonic Anhydrase Inhibitors as New Weapons to Fight Helicobacter pylori: Synthesis, Bioactivity Evaluation, In Vivo Toxicity, and Computational Studies. Pharmaceuticals 2024, 17, 1027.
https://doi.org/10.3390/ph17081027
AMA Style
Giampietro L, Marinacci B, Della Valle A, D’Agostino I, Lauro A, Mori M, Carradori S, Ammazzalorso A, De Filippis B, Maccallini C,
et al. Azobenzenesulfonamide Carbonic Anhydrase Inhibitors as New Weapons to Fight Helicobacter pylori: Synthesis, Bioactivity Evaluation, In Vivo Toxicity, and Computational Studies. Pharmaceuticals. 2024; 17(8):1027.
https://doi.org/10.3390/ph17081027
Chicago/Turabian Style
Giampietro, Letizia, Beatrice Marinacci, Alice Della Valle, Ilaria D’Agostino, Aldo Lauro, Mattia Mori, Simone Carradori, Alessandra Ammazzalorso, Barbara De Filippis, Cristina Maccallini,
and et al. 2024. "Azobenzenesulfonamide Carbonic Anhydrase Inhibitors as New Weapons to Fight Helicobacter pylori: Synthesis, Bioactivity Evaluation, In Vivo Toxicity, and Computational Studies" Pharmaceuticals 17, no. 8: 1027.
https://doi.org/10.3390/ph17081027
